ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 2604

$517K Total Retail Price of All Prescriptions

Rank: 191 out of 2604

412 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,295 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 295 149 S3 1 1
OMEPRAZOLE 239 167 2 5
SIMVASTATIN 238 195 3 2
LEVOTHYROXINE SODIUM 219 144 4 4
LISINOPRIL 205 132 5 3
FUROSEMIDE 191 142 6 8
PRAVASTATIN SODIUM 176 131 7 14
LOVASTATIN 125 88 8 24
METOPROLOL SUCCINATE 123 96 9 17
LOSARTAN-HYDROCHLOROTHIAZIDE 121 114 10 77
LOSARTAN POTASSIUM 118 101 11 20
METFORMIN HCL 114 73 12 7
METOPROLOL TARTRATE 114 102 12 9
ZOLPIDEM TARTRATE 112 94 14 21
GLIMEPIRIDE 106 78 15 57
GABAPENTIN 97 65 16 12
PROAIR HFA 92 66 17 27
PREDNISONE 90 67 18 34
FLUOXETINE HCL 89 36 19 49
AMLODIPINE BESYLATE 89 60 19 6
WARFARIN SODIUM 87 72 21 13
NAPROXEN 80 44 22 76
ADVAIR DISKUS 79 53 23 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 68 24 22
SERTRALINE HCL 77 51 25 23
TRAZODONE HCL 73 46 26 46
IPRATROPIUM BROMIDE 71 54 27 164
ATORVASTATIN CALCIUM 68 46 28 19
MELOXICAM 66 47 29 36
ATENOLOL 65 45 30 11
POTASSIUM CHLORIDE 64 57 31 16
TAMSULOSIN HCL 64 50 31 30
SPIRIVA 63 36 33 45
TIZANIDINE HCL 62 58 34 161
CRESTOR 60 38 35 47
TRAMADOL HCL 59 30 36 15
ALENDRONATE SODIUM 54 46 37 29
ACETAMINOPHEN-CODEINE 54 53 S3 37 60
SYMBICORT 53 39 39 105
ZOSTAVAX 51 42 40 90
INDAPAMIDE 51 40 40 255
HYDROCHLOROTHIAZIDE 51 32 40 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.